The Adjuvant Investment Strategy
Adjuvant’s strategy aims to drive meaningful improvements in the public health of low- and middle-income countries while pursuing top-tier financial returns. Adjuvant’s focus areas include:
- Neglected, high-burden, and emerging infectious diseases, including antimicrobial resistance and pandemic threats
- Maternal, newborn, and child health challenges
- Reproductive and sexual health
Adjuvant directs the majority of its investment activity to opportunities that have human efficacy signals from a phase II-or-later clinical trial or similar arm’s-length evaluations. We look for compelling proof-of-concept data to support our investment decisions.